US politics live: Trump goes ballistic on Musk on social media
Donald Trump's bitter feud with Elon Musk continues to escalate, with the President claiming his ex-political advisor is 'off the rails' and 'essentially becoming a train wreck'.
The latest blow comes after Mr Musk announced he was launching a new political party - a move Mr Trump has labelled 'ridiculous'.
Meanwhile, Israeli Prime Minister Benjamin Netanyahu is heading to Washington DC where he will sit down with Mr Trump on Monday (US time) in a meeting he hopes could 'help advance' a Gaza ceasefire deal.
Over in Texas, the death toll from the devastating Hill Country floods has risen to 78 – with at least 12 people still missing from Christian girls' summer camp, Camp Mystic.
Five campers have been confirmed dead in the flooding, along with the camp's owner.
Originally published as US politics live: 'Off the rails': Trump goes ballistic on Musk
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News AU
27 minutes ago
- Sky News AU
Former CIA and FBI directors now under criminal investigation
Former CIA director John Brennan and former FBI director James Comey are under criminal investigation for their handling of the Trump-Russia probe. A Justice Department source revealed to Fox News that the pair are also being investigated for allegedly making false statements to Congress. FBI Director Kash Patel was referred to evidence of potential wrongdoing by Brennan from the current CIA Director John Ratcliffe, a DOJ source said. According to Fox News, a source revealed that an investigation into Brennan is underway, but further details were not given. It is currently unclear whether the investigation into the former CIA head goes beyond his alleged false statements to Congress. An investigation into the former FBI director Comey is underway, though sources could not divulge further information.
News.com.au
31 minutes ago
- News.com.au
Top Tesla analyst urges board to rein in Musk
A leading wall street Tesla analyst has issued a warning to Tesla's board of directors, urging immediate action over chief executive Elon Musk. Wedbush managing director Dan Ives, one of Tesla's most bullish analysts, laid out a three part strategy in a Tuesday morning note that calls for greater oversight of Musk. Tesla 'needs to act now and set the ground rules for Musk going forward around his political ambitions and actions,' Ives said. Tesla's share price has dipped of late, thanks to Elon Musk's fight with President Donald Trump. Shares dropped 6 per cent on Monday following Musk's announcement of his intention to create a new political party, wiping more than USD $15 billion from his personal wealth. The stock slightly rebounded yesterday by 3 per cent, however remains down by more than 10 per cent since Musk started publicly criticising Trump last month. Ives, who has been a long-term supporter of Tesla, said Musk's attention has become increasingly fragmented as he pivots his interests towards SpaceX, xAI and politics. He suggested Tesla introduce a new compensation package that would increase Musk's voting stake to 25 per cent, up from 13 per cent if he agrees to spend a guaranteed amount of time actually working on Tesla, not just side projects like SpaceX, X or political ventures. Ives also suggested tying Musk's pay to his behaviour. He wants Musk's massive bonus to be conditional, meaning if he spends too much time on politics or things that hurt the Tesla brand, he could lose some of that bonus. Lastly, Ives suggested a watchdog group for Elon, a special board that would keep an eye on Elon's public behaviour and make sure they don't damage the company's reputation. The Board should 'create a special Board oversight committee for Musk around his political ambitions and ground rules that would violate his pay package,' Ive said. Musk responded directly to Ives' comments via a post on X, writing 'Shut up Dan'. Tesla is facing its most challenging sales period in years, with global deliveries falling in both first and second quarters of 2025. A decline that analysts believe is due to Musk's behaviour.
News.com.au
31 minutes ago
- News.com.au
‘Screw over': Truth about Donald Trump's plan to impose crippling 200 per cent tariffs on Australian pharmaceuticals
US President Donald Trump's plan to drop a 200 per cent tariff bomb on Australian pharmaceuticals is set to 'screw over' the sickest and most vulnerable in the United States suffering rare and life-threatening conditions including burns patients. As the Albanese Government scrambles to secure more information about the US government's latest plans, Australian officials are sounding the alarm given that pharmaceutical exports are worth over $2 billion a year. All plasma products collected in Australia stay here and are not exported to the US. Instead, the export issue relates to vaccines and blood products collected overseas and sent to Australia for processing before being returned to the US. President Donald Trump has threatened to introduce 200 per cent tariffs on pharmaceuticals – one of Australia's biggest exports to the US. Speaking to the media before a cabinet meeting, the President suggested the 'very, very high' levies on pharmaceuticals would not go into effect immediately, saying he would give drug manufacturers 'about a year, year and a half' to respond and relocate their operations to the US. 'They're going to be tariffs at a very high rate, like 200 per cent,' Mr Trump told reporters. 'We'll give them a certain period of time to get their act together,' he added, seemingly referring to drug manufacturers bringing back manufacturing into the US. Australia is subject to a 10 per cent 'baseline' tariff, which was the minimum rate imposed on all US trading partners by Mr Trump earlier this year. Australia's plasma exports to the US One of the biggest sections of the market includes blood products such as plasma products including exports linked to CSL Plasma which collects blood plasma in the United States. In 2023, Australia exported $1.42 billion of vaccines, blood, antisera, toxins and cultures, making it the 20th largest exporter of 208 in the world. Blood collection is a commercial operation in the United States, with plasma donors typically paid for their blood. CSL Plasma operates one of the world's largest and most sophisticated plasma collection networks, with nearly 350 plasma collection centers in the US and elsewhere. The blood products are mostly processed in the US but some are sent back to Australia to manufacture therapies for a variety of rare and life-threatening conditions. These conditions include primary immunodeficiencies, bleeding disorders like hemophilia, neurological disorders, and critical care needs like those arising from trauma or burns. One Australian official predicted that demand for the products would continue but the tariffs would 'screw over' patients relying on the notorious US healthcare system. Vulnerable patients will be hit with cost increases because the tariffs are paid by importers, not Australian exporters. CSL has a factory in Melbourne Biotech giant CSL has a plasma fractionation facility in Broadmeadows in Melbourne. The impact of the threatened tariffs relates to the commercial arm of CSL. which uses US blood products which are sourced in America and then processed in Australia before being sent back. 'Plasma manufacturing is a really fragile supply chain because it starts in a human vein,'' an industry source said. 'It's not a tap that you can turn on or off. You need people to vote with their feet to go into a facility that is enabled to collect plasma, and the demand for plasma products is growing globally each year.' 'Tariffs on pharmaceuticals impact the end user.' Treasurer Jim Chalmers 'very concerned' The Treasurer said on Wednesday that Washington's latest announcement was 'very concerning'. 'These are obviously very concerning developments,' Mr Chalmers told the ABC, adding that it had 'been a feature of recent months that we've had these sorts of announcements out of DC'. 'It's still early days. Obviously, we'll make a more detailed assessment of what's come out of the US in the usual way.' 'Our pharmaceuticals industry is much more exposed to the US market, and that's why we're seeking - urgently seeking - some more detail on what's been announced. 'But I want to make it really clear once again … our Pharmaceutical Benefit Scheme is not something that we're willing to trade away or do deals on – that won't change.' 'We've made it very clear that we think these tariffs are bad for the US, bad for Australia and bad for the global economy.' Mr Chalmers said one of the things the Albanese Government was 'most concerned' about was in addition to the direct impact on Australian workers and industries caused by this tariff, was the 'impact on global demand more broadly'. 'That's why we've been … at every opportunity, making the case that these tariffs are unjustified, they should be removed in line with our free trade agreement,' he said. The Prime Minister has described the taxes on Australian exports to the US as an 'act of economic self-harm'. 'Tariffs are a penalty on the country that is imposing them, because what they require is for goods to be purchased with a tax on top, and the US has made that decision,' the Prime Minister said. How plasma exports are used to help patients CSL Behring uses a process called plasma fractionation to separate the collected plasma into different components, such as immunoglobulins, coagulation factors, and other proteins. One example is helping people with bleeding disorders, with doctors utilising coagulation factors that are used to help patients with hemophilia and other bleeding disorders. Plasma-derived products are also used in emergency situations like severe trauma, burns, and shock to replace lost blood volume and proteins. For now, Australian officials concerned about the impact on blood product exports don't have full clarity on how it will impact the supply chain process.
